The market is digesting gains with healthy chop, shrugging off bad news, and technicals remain strong. Check out the ...

The two primary factors that lead me to make decisions in the U.S. bond market and for U.S. currency are both going up.” ...

Merck is expanding in oncology, immunology, and vaccines through acquisitions and R&D. Find out what makes MRK a stable GARP ...

A renewed wave of dip buying fueled a rebound in stocks from session lows, with traders looking past the US downgrade by ...

Manawa sells most of its power to Mercury NZ under a long-term contract with consumer price-index-linked prices. With elevated CPI inflation, revenue has a solid tailwind. Contracted sales reduce ...